ENTITY

BioLine RX (BLRX US)

12
Analysis
Health Care • Israel
BioLineRx Ltd. is a biopharmaceutical development company. The Company develops clinical-stage therapeutic pharmaceutical drugs.
more
bullish•BioLine RX
•26 Nov 2025 05:00•Issuer-paid

BLRX: Stem Cell Mobilization Presentation at ASH

BioLineRx is a commercial stage biopharmaceutical company with a development portfolio advancing motixafortide, a platform molecule targeting...

Share
bullish•BioLine RX
•01 Oct 2025 01:00•Issuer-paid

BLRX: A Venture into GBM

BioLineRx is a commercial stage biopharmaceutical company with a development portfolio advancing motixafortide, a platform molecule targeting...

Share
bullish•BioLine RX
•16 Aug 2025 04:00•Issuer-paid

BLRX: ASCO Poster & Abstract

BioLineRx is a commercial stage biopharmaceutical company with a development portfolio advancing motixafortide, a platform molecule targeting...

Share
bullish•BioLine RX
•03 Jun 2025 03:00•Issuer-paid

BLRX: First Quarter Results

BioLineRx is a commercial stage biopharmaceutical company with a development portfolio advancing motixafortide, a platform molecule targeting...

Share
bullish•BioLine RX
•28 May 2025 22:00•Issuer-paid

BLRX: First Quarter Results

BioLineRx is a commercial stage biopharmaceutical company with a development portfolio advancing motixafortide, a platform molecule targeting...

Share
x